Spero Therapeutics Inc. logo

Spero Therapeutics Inc. (SPRO)

Market Closed
18 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
1. 20
+0.01
+0.8403%
$
71.8M Market Cap
3.69 P/E Ratio
- Div Yield
475,676 Volume
-0.52 Eps
$ 1.19
Previous Close
Add Transaction
Day Range
1.18 1.2
Year Range
1.08 3.08
Want to track SPRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Spero Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Madelyn D. Purcell
Madelyn D. Purcell Pfizer Inc
2.36M $2.43M $2.81M $377,976.15 15.53%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
104,377 $237,994.05 $128,383.71 -$109,610.34 -46.06%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
10 $23 $11.7 -$11.3 -49.13%
Donald O. Dempster
Donald O. Dempster DLK Investment Management, LLC
31,355 $70,862.3 $36,685.35 -$34,176.95 -48.23%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
91,900 $202,180 $113,037 -$89,143 -44.09%
Carmen McClennon
Carmen McClennon WR Wealth Planners, LLC
2,600 $4,472 $3,042 -$1,430 -31.98%
Tory Parke
Tory Parke Three Seasons Wealth LLC
30,000 $42,150 $35,700 -$6,450 -15.3%
EG
Ethan Gilbert Rialto Wealth Management LLC
172 $381 $211.56 -$169.44 -44.47%